スマート処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

臨床ガイドラインに基づいて薬物相互作用や投与量の異常を自動的に検出し、薬剤師の処方審査効率と患者の服薬安全性の向上を支援します。

プロンプト内容

コピー

Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.

コピー

シニア臨床薬剤師として、提供された電子処方箋のコンプライアンスを審査してください。患者の現在の服薬リストにおける潜在的な薬物相互作用、禁忌症の衝突、または推奨範囲を超える投与量の有無に重点的に分析してください。リスクが特定された場合は、最新の臨床ガイドラインに基づいて具体的な問題点を指摘し、調整案を提供してください。異常がない場合は、処方が標準治療プロトコルに準拠していることを確認してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.

処方審査アシスタント

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag potential risks and suggest adjustments, ensuring the treatment plan aligns with the latest clinical guidelines.

処方箋コンプライアンス審査

Act as a senior clinical pharmacist to review the following patient prescription: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze if this prescription contains any drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of using NSAIDs in patients with renal impairment. Provide specific adjustment suggestions or alternative solutions to ensure medication safety and compliance with clinical guidelines.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions ensuring patient safety.